Results 121 to 130 of about 291,510 (309)
A Long‐Standing Palmar Depressed Macule
JEADV Clinical Practice, EarlyView.
Jhon Edwin Rodríguez‐Vásquez +4 more
wiley +1 more source
A new nanoparticle‐based biomarker panel is described that can differentiate pancreatic cancer from benign pancreatic disease with a high level of performance. This was enabled by microelectrode array recovery technology that used dielectrophoresis (DEP) to quickly and efficiently recover the nanoparticles from patient plasma samples, followed by on ...
Anna Malakian +23 more
wiley +1 more source
Line‐Field Confocal Optical Coherence Tomography (LC‐OCT) of Masson's Tumor
JEADV Clinical Practice, EarlyView.
Gerardo Palmisano +6 more
wiley +1 more source
Abstract Background Low‐grade non‐muscle‐invasive bladder cancer (NMIBC) is characterized by high recurrence rates, resulting in repeated interventions and intensive surveillance. Office‐based transurethral laser ablation (TULA) performed under local anesthesia is a minimally invasive alternative to transurethral resection, and narrow band imaging (NBI)
Ibrahim A. Khalil +6 more
wiley +1 more source
Primary Retroperitoneal Mucinous Cystic Neoplasm Involving Adrenal Gland
The Kaohsiung Journal of Medical Sciences, EarlyView.
Di‐Ping Yu +2 more
wiley +1 more source
Cancer‐associated fibroblasts exert intricate mechanisms in the progression and metastasis of renal cell carcinoma. Existing studies have validated the relevant mechanisms of three signaling pathways, which hold promising potential as novel therapeutic targets.
Ruiqiang Sun +4 more
wiley +1 more source
Thyroid-hormone therapy and thyroid cancer: a reassessment. [PDF]
Experimental studies and clinical data have demonstrated that thyroid-cell proliferation is dependent on thyroid-stimulating hormone (TSH), thereby providing the rationale for TSH suppression as a treatment for differentiated thyroid cancer.
BIONDI, BERNADETTE +2 more
core
Intraductal Papillary Carcinoma
Jolinda, Mester +3 more
openaire +2 more sources
ABSTRACT Objectives Angiopoietin‐2 (ANGPT2) is known to participate in tumor progression and immune modulation across multiple malignancies. Nevertheless, its expression pattern, prognostic value, and biological function in thyroid cancer (THCA) have not been comprehensively investigated.
Han Chen +5 more
wiley +1 more source

